CRDF
Cardiff Oncology
$0.91
+$0.01 (+1.33%)Oct 29, 2026
Key metrics
The numbers that frame CRDF today
- Market cap
- $70.95M
- Gross margin
- 100%
- EV / Sales
- 122.5
- ROIC
- -141.3%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.76
- 52wk High
- $3.31
Growth
Revenue and earnings trend for CRDF
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CRDF
Is Cardiff Oncology a good buy?
No. Cardiff Oncology has poor quality and weak momentum. Both signals point to a weaker setup. Growth looks weak. That could put pressure on the long-term business case. We think Cardiff Oncology is selling at a very high price.
What is the market capitalization of CRDF?
Cardiff Oncology's market capitalization is $70.95M.
What is the 52-week high for CRDF stock?
The 52-week high for Cardiff Oncology is $3.31. The current close of $0.91 is 72.4% below that high.
What is the 52-week low for CRDF stock?
The 52-week low for Cardiff Oncology is $0.76. The current close of $0.91 is 20.5% above that low.
Does CRDF stock pay dividends?
Cardiff Oncology does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CRDF?
Cardiff Oncology's Debt / Equity ratio is 0.02.